Concepedia

Andras Boeszoermenyi

AB

Statistics

Publications

22

Citations

2.1K

H-Index

21

Active since

2011

Affiliations

Harvard University(Current)

Dana-Farber Cancer Institute

University of Graz

Dana-Farber/Harvard Cancer Center

National Institute of Advanced Industrial Science and Technology

Andras Boeszoermenyi is an author at Harvard University specializing in life sciences, biochemistry, and molecular biology.

ORCID

Publications per year

2011–2024

22

Publications

22

An open-source drug discovery platform enables ultra-large virtual screens

Christoph Gorgulla, Andras Boeszoermenyi, Zifu Wang et al. · Nature · 2020 · 645 citations · Full text

, , +11

The Kinetochore-Bound Ska1 Complex Tracks Depolymerizing Microtubules and Binds to Curved Protofilaments

Jens C. Schmidt, Haribabu Arthanari, Andras Boeszoermenyi et al. · Developmental Cell · 2012 · 224 citations · Full text

, , +12

Inhibiting fungal multidrug resistance by disrupting an activator–Mediator interaction

Joy L. Nishikawa, Andras Boeszoermenyi, Luís A. Vale-Silva et al. · Nature · 2016 · 143 citations · Full text

, , +14

Aromatic 19F-13C TROSY: a background-free approach to probe biomolecular structure, function, and dynamics

Andras Boeszoermenyi, Sandeep Chhabra, Abhinav Dubey et al. · Nature Methods · 2019 · 133 citations · Full text

, , +7

The Minimal Domain of Adipose Triglyceride Lipase (ATGL) Ranges until Leucine 254 and Can Be Activated and Inhibited by CGI-58 and G0S2, Respectively

Irina Cornaciu, Andras Boeszoermenyi, Hanna Lindermuth et al. · PLoS ONE · 2011 · 88 citations · Full text

, , +17

1–5 of 22